US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

AUPH Aurinia Pharmaceuticals Inc

5.02

-0.15 (-2.90%)

10 May 2024 - Cerrado

Retrasado por 15 minutos

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

null

Aurinia Pharmaceuticals (NASDAQ:AUPH)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Aurinia Pharmaceuticals.

Aurinia Pharmaceuticals (NASDAQ:AUPH)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Aurinia Pharmaceuticals.

Noticias sobre Aurinia Pharmaceuticals Inc AUPH

Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024
Jueves 9 de Mayo 2024 (3 días hace) • Business Wire

Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
Martes 7 de Mayo 2024 (5 días hace) • Business Wire

Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
Jueves 2 de Mayo 2024 (1 semana hace) • Business Wire

Aurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness Month
Miércoles 1 de Mayo 2024 (2 semanas hace) • Business Wire

The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program
Martes 30 de Abril 2024 (2 semanas hace) • Business Wire

UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Martes 16 de Abril 2024 (4 semanas hace) • Business Wire

Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024
Lunes 15 de Abril 2024 (4 semanas hace) • Business Wire

Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference
Martes 9 de Abril 2024 (1 mes hace) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Jueves 7 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jueves 7 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jueves 7 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jueves 7 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Más de Aurinia Pharmaceuticals Inc Artículos de Noticias

Invesco QQQ Trust Series 1

BNP Paribas (QX)

Financial Select Sector

Verizon Communications

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones